日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study

罗沙司他治疗肾衰竭贫血的随机试验：SIERRAS 研究

期刊:Kidney International Reports
影响因子:5.7
doi:10.1016/j.ekir.2021.04.007
Charytan, Chaim; Manllo-Karim, Roberto; Martin, Edouard R; Steer, Dylan; Bernardo, Marializa; Dua, Sohan L; Moustafa, Moustafa A; Saha, Gopal; Bradley, Charles; Eyassu, Meraf; Leong, Robert; Saikali, Khalil G; Liu, Cameron; Szczech, Lynda; Yu, Kin-Hung P
RAS
贫血
代谢
发表日期：2021
文献求助 收藏

Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease

Vadadustat治疗3期或4期慢性肾脏病继发性贫血患者的临床试验

期刊:American Journal of Nephrology
影响因子:3.2
doi:10.1159/000464476
Martin, Edouard R; Smith, Mark T; Maroni, Bradley J; Zuraw, Qing C; deGoma, Emil M
贫血
代谢
发表日期：2017
文献求助 收藏

An open-label, sequential, dose-finding study of peginesatide for the maintenance treatment of anemia in chronic hemodialysis patients

一项开放标签、序贯、剂量探索性研究，旨在评估培吉沙肽用于慢性血液透析患者贫血维持治疗的疗效。

期刊:BMC Nephrology
影响因子:2.4
doi:10.1186/1471-2369-13-95
Besarab, Anatole; Zeig, Steven N; Martin, Edouard R; Pergola, Pablo E; Whittier, Frederick C; Zabaneh, Raja I; Schiller, Brigitte; Mayo, Martha; Francisco, Carol A; Polu, Krishna R; Duliege, Anne-Marie
贫血
代谢
发表日期：2012
文献求助 收藏